Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Arginine in Falciparum Malaria
NCT00147368Phase 2Completed
- Sponsor
- Menzies School of Health Research
- Start
- Feb 2005
- Primary completion
- Apr 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in Malaria, sponsored by Menzies School of Health Research. Started Feb 2005; status: completed.
02
Drugs
arginine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00147368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147368.